Asia Pacific Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
The APAC anti-infective agents market was valued at US$ 35,281.27 million in 2022 and is projected to reach US$ 43,478.22 million by 2028. It is expected to grow at a CAGR of 3.5% during the forecast period.
Continued development of new anti-infective agents is a major driving force behind the growth of the Asia Pacific anti-infective agents market. Developments in the medical devices industry have motivated existing players and new entrants to introduce their novel products in the market. Additionally, there have been lots of developments in techniques involved in medical examinations. The use of illuminating light sources with longer shelf life in gynecological procedures is encouraging market players to develop and introduce anti-infective agents.
TLRs, or toll-like receptors, are important components of innate immunity. They have the ability to detect a variety of microbes, including viruses, bacteria, fungi, and protozoa. Innate immunological reactions can directly influence adaptive immune reactions. Therefore, TLRs are considered therapeutic targets for autoimmune diseases, including autoimmune disorders, allergies, sepsis, and cancer. 2 COVID-19 vaccines were created using mRNA technology (Pfizer-BioNTech35 and Moderna36), demonstrating safety and high efficacy. Such developments are expected to present lucrative opportunities to the Asia Pacific anti-infective agent market in the years to come.
Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the Asia Pacific anti-infective agents market at a good CAGR during the forecast period.
Asia Pacific Anti-Infective AgentsMarket Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Anti-Infective Agents Market Segmentation
The Asia Pacific anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.
Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.
Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.
Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.
Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.
Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China is expected to hold the largest market share by the end of 2022.
Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the Asia Pacific anti-infective agents market.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Anti-Infective Agents Market – By Type
1.3.2 APAC Anti-Infective Agents Market – By Range
1.3.3 APAC Anti-Infective Agents Market – By Route of Administration
1.3.4 APAC Anti-Infective Agents Market – By Indication
1.3.5 APAC Anti-Infective Agents Market – By Distribution Channel
1.3.6 APAC Anti-Infective Agents Market – By Country
2. APAC Anti-Infective Agents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Anti-infective agents Market – Market Landscape
4.1 Overview
4.2 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Anti-Infectives Agents Market – Key Market Dynamics
5.1 Key Drivers
5.1.1 Rising Prevalence of Targeted Diseases
5.1.2 Research Activities and Clinical Trials Getting Government Support
5.2 Market Restraints
5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
5.3.1 New Anti-infective Agents Getting Developed
5.4 Future Trends
5.4.1 Surging Investments in R&D Activities in Pharmaceutical Sector
5.5 Impact Analysis
6. Anti-Infectives Agents Market – APAC Analysis
6.1 APAC Anti-Infectives Agents Market Revenue Forecast and Analysis
7. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 – Type
7.1 Overview
7.2 APAC Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.3 Anti-Viral
7.3.1 Overview
7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Bacterial
7.4.1 Overview
7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.5 Anti-Fungal
7.5.1 Overview
7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 – Range
8.1 Overview
8.2 APAC Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
8.3.1 Overview
8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
8.4.1 Overview
8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 – Route of Administration
9.1 Overview
9.2 APAC Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
9.3.1 Overview
9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
9.5.1 Overview
9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 – Indication
10.1 Overview
10.2 APAC Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
10.4.1 Overview
10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
10.5.1 Overview
10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
10.6.1 Overview
10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. APAC Anti-Infectives Agents Market Analysis and Forecast to 2028 – Distribution Channel
11.1 Overview
11.2 APAC Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
11.5.1 Overview
11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
11.6.1 Overview
11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. APAC Anti-Infectives Agents Market Analysis and Forecasts To 2028 – Country Analysis
12.1 Overview
12.1.2 APAC: Anti-infective agents Market, by Country, 2022 & 2028 (%)
12.1.2.1 China: Anti-infective agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.1 China: Anti-infective agents Market – Revenue and Forecast to 2028 (US$ Million)
12.1.2.1.2 China: Anti-infective agents Market, by Type, 2019–2028 (US$ Million)
12.1.2.1.3 China: Anti-infective agents Market, by Range, 2019–2028 (US$ Million)
12.1.2.1.4 China: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.1.2.1.5 China: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.1.2.1.6 China: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.1.2.2 Japan: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Japan: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 Japan: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.1.2.2.3 Japan: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.1.2.2.4 Japan: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.1.2.2.5 Japan: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.1.2.2.6 Japan: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.1.2.3 India: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 India: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 India: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.1.2.3.3 India: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.1.2.3.4 India: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.1.2.3.5 India: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.1.2.3.6 India: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.1.2.4 South Korea: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 South Korea: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 South Korea: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.1.2.4.3 South Korea: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.1.2.4.4 South Korea: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.1.2.4.5 South Korea: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.1.2.4.6 South Korea: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.1.2.5 Australia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.1 Australia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.2 Australia: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.1.2.5.3 Australia: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.1.2.5.4 Australia: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.1.2.5.5 Australia: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.1.2.5.6 Australia: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
12.1.2.6 Rest of APAC: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.1 Rest of APAC: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.2 Rest of APAC: Anti-infective agents Market, by Type, 2019–2028 (USD Million)
12.1.2.6.3 Rest of APAC: Anti-infective agents Market, by Range, 2019–2028 (USD Million)
12.1.2.6.4 Rest of APAC: Anti-infective agents Market, by Route of Administration, 2019–2028 (USD Million)
12.1.2.6.5 Rest of APAC: Anti-infective agents Market, by Indication, 2019–2028 (USD Million)
12.1.2.6.6 Rest of APAC: Anti-infective agents Market, by Distribution Channel, 2019–2028 (USD Million)
13. Anti-infectives Agents Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
13.3 Organic Developments
13.3.1 Overview
13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
13.4 Inorganic Developments
13.4.1 Overview
13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022
14. Anti-Infectives Agents Market- Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Allergan Plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co., Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bayer AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Boehringer Ingelheim International GmbH
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Gilead Sciences, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 GlaxoSmithKline plc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Novartis AG
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. China Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 4. China Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 5. China Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 6. Japan Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 8. Japan Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. Japan Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 10. Japan Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 11. India Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 12. India Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 13. India Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 14. India Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. India Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 17. South Korea Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 18. South Korea Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 19. South Korea Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 20. South Korea Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 21. Australia Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Australia Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 23. Australia Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 24. Australia Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 25. Australia Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of APAC Anti-infective agents Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of APAC Anti-infective agents Market, by Range– Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of APAC Anti-infective agents Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of APAC Anti-infective agents Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of APAC Anti-infective agents Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 31. Recent Inorganic Growth Strategies In The Anti-infective agents Market
Table 32. Glossary of Terms, APAC Anti-infectives Agents Market
LIST OF FIGURES
Figure 1. APAC Anti-Infective Agents Market Segmentation
Figure 2. APAC Anti-Infective Agents Market Segmentation, by Country
Figure 3. APAC Anti-infective agents Market Overview
Figure 4. Anti-Viral Segment Held Largest Share of Product Segment in APAC Anti-Infective Agents Market
Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. APAC: PEST Analysis
Figure 7. Experts Opinion
Figure 8. APAC Anti-Infectives Agents Market Impact Analysis of Drivers and Restraints
Figure 9. APAC Anti-infectives agents Market– Revenue Forecast and Analysis – 2019 - 2028
Figure 10. APAC Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
Figure 11. APAC Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
Figure 16. APAC Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
Figure 19. APAC IV Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. APAC Oral Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Topical Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
Figure 24. APAC HIV Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. APAC Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
Figure 30. APAC Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. APAC Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. APAC Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. APAC E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. APAC Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. APAC: Anti-infective agents Market, by Key Country – Revenue (2022) (US$ Million)
Figure 36. China: Anti-infective agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. Japan: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. India: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. South Korea: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Australia: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Rest of APAC: Anti-infective agents Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Growth Strategies In The Anti-infective agents Market, 2018-2022
Figure 43. Recent Organic Growth Strategies In The Anti-infective agents Market
- Abbott
- Allergan Plc.
- Astellas Pharma Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific anti-infective agents market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific anti-infective agents market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the anti-infective agents market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution